Evolution, role in inflammation, and redox control of leaderless secretory proteins

J Biol Chem. 2020 May 29;295(22):7799-7811. doi: 10.1074/jbc.REV119.008907. Epub 2020 Apr 24.

Abstract

Members of the interleukin (IL)-1 family are key determinants of inflammation. Despite their role as intercellular mediators, most lack the leader peptide typically required for protein secretion. This lack is a characteristic of dozens of other proteins that are actively and selectively secreted from living cells independently of the classical endoplasmic reticulum-Golgi exocytic route. These proteins, termed leaderless secretory proteins (LLSPs), comprise proteins directly or indirectly involved in inflammation, including cytokines such as IL-1β and IL-18, growth factors such as fibroblast growth factor 2 (FGF2), redox enzymes such as thioredoxin, and proteins most expressed in the brain, some of which participate in the pathogenesis of neurodegenerative disorders. Despite much effort, motifs that promote LLSP secretion remain to be identified. In this review, we summarize the mechanisms and pathophysiological significance of the unconventional secretory pathways that cells use to release LLSPs. We place special emphasis on redox regulation and inflammation, with a focus on IL-1β, which is secreted after processing of its biologically inactive precursor pro-IL-1β in the cytosol. Although LLSP externalization remains poorly understood, some possible mechanisms have emerged. For example, a common feature of LLSP pathways is that they become more active in response to stress and that they involve several distinct excretion mechanisms, including direct plasma membrane translocation, lysosome exocytosis, exosome formation, membrane vesiculation, autophagy, and pyroptosis. Further investigations of unconventional secretory pathways for LLSP secretion may shed light on their evolution and could help advance therapeutic avenues for managing pathological conditions, such as diseases arising from inflammation.

Keywords: Toll-like receptor (TLR); cryopyrin-associated periodic syndrome (CAPS); gasdermin D; inflammation; innate immune response; innate immunity; interleukin 1 (IL-1); leaderless secretory proteins; lysosome; misfolding; monocyte; oxidation-reduction (redox); reactive oxygen species (ROS); secretion; secretory lysosomes; stress; unconventional protein secretion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autophagy
  • Evolution, Molecular*
  • Exocytosis
  • Exosomes / genetics
  • Exosomes / metabolism
  • Exosomes / pathology
  • Fibroblast Growth Factor 2 / genetics
  • Fibroblast Growth Factor 2 / metabolism*
  • Humans
  • Inflammation / genetics
  • Inflammation / metabolism
  • Inflammation / pathology
  • Interleukin-18 / genetics
  • Interleukin-18 / metabolism*
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism*
  • Lysosomes / genetics
  • Lysosomes / metabolism
  • Lysosomes / pathology
  • Protein Processing, Post-Translational*
  • Pyroptosis
  • Secretory Pathway*

Substances

  • IL18 protein, human
  • IL1B protein, human
  • Interleukin-18
  • Interleukin-1beta
  • Fibroblast Growth Factor 2